Development and Internal Validation of a Risk Assessment Tool to Identify Neonates at Risk for 60-Day Hospital Readmission in Dar es Salaam, Tanzania, and Monrovia, Liberia.
IF 1.9 4区 医学Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Rodrick R Kisenge, Evance Godfrey, Readon C Ideh, Julia Kamara, Ye-Jeung Coleman-Nekar, Abraham Samma, Hussein K Manji, Christopher R Sudfeld, Adrianna Westbrook, Michelle Niescierenko, Claudia R Morris, Cynthia G Whitney, Robert F Breiman, Christopher P Duggan, Karim P Manji, Chris A Rees
{"title":"Development and Internal Validation of a Risk Assessment Tool to Identify Neonates at Risk for 60-Day Hospital Readmission in Dar es Salaam, Tanzania, and Monrovia, Liberia.","authors":"Rodrick R Kisenge, Evance Godfrey, Readon C Ideh, Julia Kamara, Ye-Jeung Coleman-Nekar, Abraham Samma, Hussein K Manji, Christopher R Sudfeld, Adrianna Westbrook, Michelle Niescierenko, Claudia R Morris, Cynthia G Whitney, Robert F Breiman, Christopher P Duggan, Karim P Manji, Chris A Rees","doi":"10.4269/ajtmh.24-0648","DOIUrl":null,"url":null,"abstract":"<p><p>Hospital readmissions among neonates are common and may reflect ongoing illness. We conducted a prospective observational cohort study of neonates discharged from two hospitals, one in Dar es Salaam, Tanzania, and one in Monrovia, Liberia, to develop and internally validate a risk assessment tool to identify neonates at risk for unplanned readmission within 60 days of discharge. One hundred and fifteen candidate variables were collected. The outcome of unplanned readmission was identified through phone calls to caregivers. We constructed a multivariable logistic regression model with best subset selection to identify the optimal combination of variables to identify neonates at risk for readmission. We used bootstrap validation with 500 repetitions to internally validate the tool. Of the 2,344 neonates discharged, 98.5% were enrolled and had 60-day outcomes. Of these, 3.6% were readmitted within 60 days of discharge, with 41.7% of readmissions occurring within 14 days of discharge. The risk assessment tool included eight variables that were predictive of readmissions. Neonates who had documented abnormal posturing during hospital admission (adjusted odds ratio [aOR] 7.29, 95% CI 1.51-35.12), hydrocephalus (aOR 7.52, 95% CI 1.21-46.95), and low birth weight (aOR 3.16, 95% CI 1.69-5.92) had the greatest risk of readmission. The overall discriminatory value of the risk assessment tool was 0.77 (95% CI 0.76-0.79). The risk assessment tool demonstrated excellent calibration for predicting readmissions at low scores. However, this tool requires external validation before it can be used in sub-Saharan Africa to direct resources for follow-up of high-risk neonates.</p>","PeriodicalId":7752,"journal":{"name":"American Journal of Tropical Medicine and Hygiene","volume":" ","pages":"1378-1384"},"PeriodicalIF":1.9000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Tropical Medicine and Hygiene","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4269/ajtmh.24-0648","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/4 0:00:00","PubModel":"Print","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Hospital readmissions among neonates are common and may reflect ongoing illness. We conducted a prospective observational cohort study of neonates discharged from two hospitals, one in Dar es Salaam, Tanzania, and one in Monrovia, Liberia, to develop and internally validate a risk assessment tool to identify neonates at risk for unplanned readmission within 60 days of discharge. One hundred and fifteen candidate variables were collected. The outcome of unplanned readmission was identified through phone calls to caregivers. We constructed a multivariable logistic regression model with best subset selection to identify the optimal combination of variables to identify neonates at risk for readmission. We used bootstrap validation with 500 repetitions to internally validate the tool. Of the 2,344 neonates discharged, 98.5% were enrolled and had 60-day outcomes. Of these, 3.6% were readmitted within 60 days of discharge, with 41.7% of readmissions occurring within 14 days of discharge. The risk assessment tool included eight variables that were predictive of readmissions. Neonates who had documented abnormal posturing during hospital admission (adjusted odds ratio [aOR] 7.29, 95% CI 1.51-35.12), hydrocephalus (aOR 7.52, 95% CI 1.21-46.95), and low birth weight (aOR 3.16, 95% CI 1.69-5.92) had the greatest risk of readmission. The overall discriminatory value of the risk assessment tool was 0.77 (95% CI 0.76-0.79). The risk assessment tool demonstrated excellent calibration for predicting readmissions at low scores. However, this tool requires external validation before it can be used in sub-Saharan Africa to direct resources for follow-up of high-risk neonates.
新生儿再入院是常见的,可能反映了持续的疾病。我们对两家医院(分别位于坦桑尼亚达累斯萨拉姆和利比里亚蒙罗维亚)出院的新生儿进行了前瞻性观察队列研究,以开发并内部验证一种风险评估工具,以识别出院后60天内有意外再入院风险的新生儿。共收集了115个候选变量。意外再入院的结果是通过打电话给护理人员确定的。我们构建了一个具有最佳子集选择的多变量逻辑回归模型,以确定变量的最佳组合,以确定有再入院风险的新生儿。我们使用了500次重复的引导验证来内部验证该工具。在2,344名出院的新生儿中,98.5%的人入组,并有60天的预后。其中3.6%的患者在出院后60天内再次入院,41.7%的患者在出院后14天内再次入院。风险评估工具包括8个预测再入院的变量。入院时体位异常(校正优势比[aOR] 7.29, 95% CI 1.51-35.12)、脑积水(aOR 7.52, 95% CI 1.21-46.95)和低出生体重(aOR 3.16, 95% CI 1.69-5.92)的新生儿再入院风险最大。风险评估工具的总体判别值为0.77 (95% CI 0.76-0.79)。风险评估工具在预测低分患者再入院方面表现出色。然而,这一工具需要外部验证,才能在撒哈拉以南非洲地区用于指导高危新生儿随访的资源。
期刊介绍:
The American Journal of Tropical Medicine and Hygiene, established in 1921, is published monthly by the American Society of Tropical Medicine and Hygiene. It is among the top-ranked tropical medicine journals in the world publishing original scientific articles and the latest science covering new research with an emphasis on population, clinical and laboratory science and the application of technology in the fields of tropical medicine, parasitology, immunology, infectious diseases, epidemiology, basic and molecular biology, virology and international medicine.
The Journal publishes unsolicited peer-reviewed manuscripts, review articles, short reports, images in Clinical Tropical Medicine, case studies, reports on the efficacy of new drugs and methods of treatment, prevention and control methodologies,new testing methods and equipment, book reports and Letters to the Editor. Topics range from applied epidemiology in such relevant areas as AIDS to the molecular biology of vaccine development.
The Journal is of interest to epidemiologists, parasitologists, virologists, clinicians, entomologists and public health officials who are concerned with health issues of the tropics, developing nations and emerging infectious diseases. Major granting institutions including philanthropic and governmental institutions active in the public health field, and medical and scientific libraries throughout the world purchase the Journal.
Two or more supplements to the Journal on topics of special interest are published annually. These supplements represent comprehensive and multidisciplinary discussions of issues of concern to tropical disease specialists and health issues of developing countries